| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.184 | 857 | 0 | 187 | 0 | 1.888 | 746 | 305 | 136 | 1.303 |
| Total Income - EUR | 2.184 | 857 | 0 | 187 | 0 | 1.888 | 746 | 305 | 136 | 1.303 |
| Total Expenses - EUR | 1.564 | 591 | 1.576 | 639 | 494 | 295 | 279 | 365 | 540 | 1.164 |
| Gross Profit/Loss - EUR | 619 | 266 | -1.576 | -451 | -494 | 1.593 | 468 | -60 | -404 | 139 |
| Net Profit/Loss - EUR | 556 | 240 | -1.576 | -457 | -494 | 1.537 | 445 | -69 | -404 | 100 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Danamedical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.315 | 2.292 | 2.253 | 2.211 | 1.948 | 1.626 | 1.312 | 1.036 | 1.361 | 926 |
| Current Assets | 4.557 | 4.765 | 920 | 451 | 58 | 1.935 | 2.583 | 2.810 | 2.070 | 2.665 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 4.473 | 4.765 | 920 | 451 | 58 | 1.935 | 2.583 | 2.810 | 2.070 | 2.665 |
| Shareholders Funds | 2.510 | 2.724 | 1.102 | 625 | 120 | 1.654 | 2.063 | 2.000 | 1.590 | 1.681 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.362 | 4.333 | 2.070 | 2.038 | 1.886 | 1.907 | 1.832 | 1.846 | 1.841 | 1.910 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Danamedical S.r.l.